Analyst Whitney Ijem from Canaccord Genuity maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) and increased the ...

“I believe NEJM recognized the gap in knowledge among all providers, for early diagnosis of uterine fibroids, especially in young patients and those presenting with anemia.” The l ess invasive ...

Reports suggest that scurvy, a disease prevalent among sailors and fishermen centuries ago, is making a resurgence.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Abnormal concentrations can be a sign of conditions ranging from iron deficiency anemia to iron overload disorders. The test ...

Belzutifan has a “generally manageable” safety profile in patients with RCC, with a relatively low rate of treatment discontinuation.

Leeman is currently 20 years old and has faced numerous difficulties, such as ADHD, sickle cell anemia, and bipolar disorder, ...

An international team of researchers has provided a genetic diagnosis for 30 individuals whose condition was undiagnosed for years despite extensive clinical or genetic testing.

Akebia Therapeutics ( (AKBA) ) has released its Q3 earnings. Here is a breakdown of the information Akebia Therapeutics presented to its ...

An international team of researchers has provided a genetic diagnosis for 30 individuals whose condition was undiagnosed for ...

RP-L102, which the firm designed to treat a form of disease caused by FANCA mutations, is already under review with the European Medicines Agency.

Inhibition of CDK6 may prevent arteriovenous malformations in hereditary hemorrhagic telangiectasia by regulating endothelial ...